🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
This is a multicentre, randomized, single-blind, active-controlled, paralle...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-09-27
Trial ID
NCT01687283
Treatments Being Tested
This will be a multi-center, randomized, placebo-controlled parallel-group ...
Status
Completed
Location
Greenville Pharmaceutical research, Inc.
Start Date
2012-03
Trial ID
NCT01516073
Treatments Being Tested
This is a parallel-group, Phase 2, randomized, double-blind, placebo-contro...
Status
Active Not Recruiting
Location
The Center for Clinical Trials - Saraland- Site Number : 8400096
Start Date
2024-11-07
Trial ID
NCT06676319
This purpose of this study is to determine the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00562159
This is a prospective study. It enrolls subjects with allergic rhinitis, wi...
Status
Not Yet Recruiting
Location
Huiying Wang
Start Date
2025-08
Trial ID
NCT07114107
Therapeutic strategies for eosinophilic esophagitis (EoE) actually include:...
Status
Completed
Location
Departments of Pediatrics, Sapienza - University of Rome
Start Date
2012-11
Trial ID
NCT01846962
Treatments Being Tested
The purpose of the study is to investigate the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00550550
The primary aim of the pilot (SAPS) protocol is to determine the feasibilit...
Status
Completed
Location
Airway Research & Clinical Trials Center
Start Date
2012-10
Trial ID
NCT01696214
Treatments Being Tested
This is a randomized, double-blind, multi-dose, parallel group trial which ...
Status
Completed
Location
Investigative Site
Start Date
2010-08
Trial ID
NCT01168310